Registries: An alternative for clinical trials?



Similar documents
The Changing Regulatory Requirements for Applied Human Pharmacology. Thomas Sudhop Federal Institute for Drugs and Medical Devices (BfArM)

20 & 21 October 2005 Clinical trials Risk issues within a wider Europe. Adrien Collovray Marsh Life Science Conference 2005 Berlin, Germany

Response of the German Medical Association

Definition of Investigational Medicinal Products (IMPs) Definition of Non Investigational Medicinal Products (NIMPs)

Guideline on good pharmacovigilance practices (GVP)

Standard Operating Procedure. Clinical Trial Authorisation

Archiving of Clinical Trial Data and Essential Documentation JCTO/CT/SOP 4.0. Joint Clinical Trials Office. Stuart Hatcher, JCTO Archivist

European Federation of Pharmaceutical Industries and Associations (EFPIA) HCP/HCO Disclosure Transparency Requirements Methodology Note for Shire

Study Design and Statistical Analysis

CURRICULUM VITAE. M. Sc. Anne-Katharina Schiefele

Guideline on good pharmacovigilance practices (GVP)

Allgemeine Rahmenbedingungen für die Entwicklung und Zulassung von Orphan Medicinal Products

Sheffield Kidney Institute. Planning a Clinical Trial

Legal and governance framework

Is it time for a new drug development paradigm?

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT OF POST-MARKETING SURVEILLANCE STUDIES OF VETERINARY MEDICINAL PRODUCTS

Medical Care in Germany

EMEA RM DRAFT GUIDANCE ISPE RESPONSE 1

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)

Vergleich der Versionen von Kapitel 1 des EU-GMP-Leitfaden (Oktober 2012) 01 July November Januar 2013 Kommentar Maas & Peither

GENERAL CONSIDERATIONS FOR CLINICAL TRIALS E8

Statistics on Long Distance Transportation by Buses and coaches

Template for essential information to be provided for proposals including clinical trials / studies / investigations

Trial Description. DRKS-ID: DRKS Date of Registration in DRKS: 2015/03/06 Date of Registration in Partner Registry: [---]*

The European Clinical Trials Framework Update on the Draft Clinical Trials Regulation

Trial Description. Organizational Data. Secondary IDs

Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials

ICH Topic E 8 General Considerations for Clinical Trials. Step 5 NOTE FOR GUIDANCE ON GENERAL CONSIDERATIONS FOR CLINICAL TRIALS (CPMP/ICH/291/95)

Mit einem Auge auf den mathema/schen Horizont: Was der Lehrer braucht für die Zukun= seiner Schüler

Feasibility study to evaluate the usability of the newly developed health care management software ecare*seniors in primary care practices.

Graduate Program Objective #1 Course Objectives

Avastin in Metastatic Breast Cancer

Glossary of Clinical Trial Terms

Mary B Codd. MD, MPH, PhD, FFPHMI UCD School of Public Health, Physiotherapy & Pop. Sciences

EU Clinical Trials Register. An agency of the European Union

The new European clinical trials regulation Dr. N.Gökbuget

AnyWeb AG

The College of Family Physicians of Canada. Position Statement Prescribing Rights for Health Professionals

Berufsakademie Mannheim University of Co-operative Education Department of Information Technology (International)

Post-authorisation safety studies and the EU PAS Register

Master of Science in Medical Writing Curriculum*

Thomas Ragni (Seco, CH): SAPS for choosing effective measures in Switzerland SAPS. Statistically Assisted Program Selection

RESEARCH INVOLVING HUMAN SUBJECTS

LEHMAN BROTHERS SECURITIES N.V. LEHMAN BROTHERS (LUXEMBOURG) EQUITY FINANCE S.A.

Raiffeisenlandesbank Oberösterreich Aktiengesellschaft

Dopaminergic and cholinergic modulation of oculomotor control during saccades

Biostatistics and Epidemiology within the Paradigm of Public Health. Sukon Kanchanaraksa, PhD Marie Diener-West, PhD Johns Hopkins University

Clinical research: where are we with the new (Paediatric) RC trial Regulation

CURRICULUM VITAE. M. Sc. Anne-Katharina Schiefele

Internationale Gute Praxis für den Umgang mit Baggergut

Global Policy on Interactions with Healthcare Professionals

HYPO TIROL BANK AG. EUR 5,750,000,000 Debt Issuance Programme (the "Programme")

Biobank Alliance. H.-Erich Wichmann. English version. Helmholtz Zentrum München LMU München

Moderator: J van Loon,MSc Mapi. Advisor to the President, Head of International Affairs, HAS France

Competencies for the nurse practitioner scope of practice

Compliance issues for pharmaceutical companies in Germany

Brief intervention in a general hospital for problematic prescription drug use: Outcome at 3- and 12-month follow-up

Not All Clinical Trials Are Created Equal Understanding the Different Phases

Research on Research: Learning about Phase 1 Trials

Use of routinely collected electronic healthcare data: Lessons Learned

Secondary Use of the EHR via Pseudonymisation

American Academy of Neurology Section on Neuroepidemiology Resident Core Curriculum

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

MN-NP GRADUATE COURSES Course Descriptions & Objectives

Clinical Study Design and Methods Terminology

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE

Guidance notes. for Patient Safety and Pharmacovigilance in Patient Support Programmes

AAMC Project to Document the Effects of HIPAA on Research

History and Principles of Good Clinical Practice

Clinical Trials at PMH

Kapitel 2 Unternehmensarchitektur III

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

NSW Cancer Trials Network Network Portfolio Policy October 2012

Key considerations for outsourcing late phase clinical research

UMEÅ INTERNATIONAL SCHOOL

Medicine Safety Glossary

EU Clinical Trials Register

University of Maryland School of Medicine Master of Public Health Program. Evaluation of Public Health Competencies

DZIF-Product Development Unit (PDU)

Department/Academic Unit: Public Health Sciences Degree Program: Biostatistics Collaborative Program

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Transitioning a Pain Program Away From Chronic Opioid Prescribing

Guidance for the format and content of the protocol of non-interventional post-authorisation safety studies

EphMRA Adverse Event Reporting Guidelines 2013

Andreas Cseh. Quantum Fading. Strategies for Leveraged & Inverse ETFs. Anchor Academic Publishing. disseminate knowledge

Ethical Considerations for Clinical Trials performed in Children

Clinical Trials: Questions and Answers

How to evaluate medications in Multiple Sclerosis when placebo controlled RCTs are not feasible

TGN 1412 Welche Änderungen haben sich für die Erstanwendung am Menschen aus Sicht des BfArM ergeben?

Masters Learning mode (Форма обучения)

Office of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD

FINLAND ON A ROAD TOWARDS A MODERN LEGAL BIOBANKING INFRASTRUCTURE

The Trials and Tribulations of the CRM: the DFO Experience

Die Toronto Konferenz. K. Arasteh Auguste-Viktoria-Klinikum

How To Be A Health Care Worker

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON RISK MANAGEMENT SYSTEMS FOR MEDICINAL PRODUCTS FOR HUMAN USE

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health

LEADING RESEARCH MEASURES THAT COUNT

Having regard to the Treaty establishing the European Community, and in particular Article 95 thereof,

Transcription:

Registries: An alternative for clinical trials? Prof. Dr. Joerg Hasford, M.D., Ph.D. Department of Medical Informatics, Biometry and Epidemiology Ludwig-Maximilians-Universität Email: has@ibe.med.uni-muenchen.de

Legal Aspects EU Directive 2001/20/EC Definitions clinical trial : Any investigation in human subjects intended to discover or verify the clinical, pharmacological and/or other pharmacodynamic effects of one or more investigational medicinal product(s), and/or to identify any adverse reactions to one or more investigational medicinal product(s) and/or study absorption, distribution, metabolism and excretion of one or more investigational medicinal product(s) with the object of ascertaining its (their) safety and/or efficacy;

Legal Aspects EU Directive 2001/20/EC Definitions non-interventional trial : A study where the medicinal product(s) is (are) prescribed in the usual manner in accordance with the terms of the marketing authorisation. The assignment of the patient to a particular therapeutic strategy is not decided in advance by a trial protocol but falls within current practice and the prescription of the medicine is clearly separated from the decision to include the patient in the study. No additional diagnostic or monitoring procedures shall be applied to the patients and epidemiological methods shall be used for the analysis of collected data;

Anwendungsbeobachtung: Rechtliche Definition 4 AMG (23) Klinische Prüfung bei Menschen ist jede am Menschen durchgeführte Untersuchung, die dazu bestimmt ist, klinische oder pharmakologische Wirkungen von Arzneimitteln zu erforschen oder nachzuweisen oder Nebenwirkungen festzustellen oder die Resorption, die Verteilung, den Stoffwechsel oder die Ausscheidung zu untersuchen, mit dem Ziel, sich von der Unbedenklichkeit oder Wirksamkeit der Arzneimittel zu überzeugen.

Satz 1 gilt nicht für eine Untersuchung, die eine nichtinterventionelle Prüfung ist. Nichtinterventionelle Prüfung ist eine Untersuchung, in deren Rahmen Erkenntnisse aus der Behandlung von Personen mit Arzneimitteln gemäß den in der Zulassung festgelegten Angaben für seine Anwendung anhand epidemiologischer Methoden analysiert werden; dabei folgt die Behandlung einschließlich der Diagnose und Überwachung nicht einem vorab festgelegten Prüfplan, sondern ausschließlich der ärztlichen Praxis.

Non-interventional Studies Different Definitions by Regulatory Authorities and Academic / Scientific Community Regulatory Authorities The term interventional refers to any directions for treatment, diagnostics, follow-up schedules in the study plan etc. current practice

Non-interventional Studies Academic / Medical scientific Differentiates interventional study and observational study (e.g. cohort-, case control-study) Intervention typically refers to directions for treatment only randomized clinical trial Current absurdity Drug regulation considers most observational studies like cohort or case control studies as interventional trials as there are directions for diagnostics and follow-up in the research plan.

Registries A registry is a file of data concerning all cases of a particular disease or exposure in a defined population such that the cases can be related to a population base

Non-interventional Studies (NIS) Registries Research Objectives most often disease-specific, e.g. cancer registries epidemiology of disease health services research (Versorgungsforschung) - Quality of care, e.g. compliance with guidelines - Outcome quality - Utilisation of resources

Non-interventional Studies (NIS) Registries In- and exclusion criteria for patients disease-specific representativity, routine care settings total population within a specified region and time frame Caveat: No additional, registry-specific diagnostics or follow-up schedules

Non-interventional Studies (NIS) Registries In- and exclusion criteria for participating centers Representativity routine care settings

Non-interventional Studies (NIS) Registries Treatment / interventions no registry-specific directions for treatment at all stages of the diseases treatment (decisions) fall completely within current practice and / or the needs of the individual patients.

Non-interventional Studies (NIS) Registries Design population-based cohort study physician-based no a priori hypotheses Follow-up no registry-specific directions ( drug-specific registries most often no NIS)

Non-interventional Studies (NIS) Registries Sample size estimation depending to the objectives usual orientation: desired precision of the result witdth of the 95%-CI

Non-interventional Studies (NIS) Registries Statistical analysis descriptive either as a cross-sectional or cohort study sophisticated methods like Cox model etc feasible, too

Non-interventional Studies (NIS) Registries Limitations Representativity often hard to achieve, non participation selection bias most often no valid data re efficacy and safety (high quality registries may allow to assess effectiveness prospective registries may experience ethical problems DSMB / DMC recommended

NIS Registries and ethics committees (German law) There is no legal requirement in Germany to consult an EC for a NIS In some German States professional regulations ask for consultation of an EC prior to the start of any epidemiologic study collecting personalized data anonymous data only no requirement

Position of the ECs Current state of the art Research logic Choice of the most efficient design re validity of the results Good epidemiology practice (GEP) guidelines

Conclusions Registries are population-based cross-sectional or longitudinal observational data. High quality data require directions and uniform standards for diagnostics and follow-up. Registries with high quality data will usually not fulfill the legal criteria of a non-interventional study (NIS). Given the different objectives registries and clinical trials complement each others but should not be considered as alternatives.